These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 18422747)

  • 1. Anticancer activity of RecQL1 helicase siRNA in mouse xenograft models.
    Futami K; Kumagai E; Makino H; Sato A; Takagi M; Shimamoto A; Furuichi Y
    Cancer Sci; 2008 Jun; 99(6):1227-36. PubMed ID: 18422747
    [TBL] [Abstract][Full Text] [Related]  

  • 2. RecQL1 DNA repair helicase: A potential tumor marker and therapeutic target against hepatocellular carcinoma.
    Futami K; Ogasawara S; Goto H; Yano H; Furuichi Y
    Int J Mol Med; 2010 Apr; 25(4):537-45. PubMed ID: 20198302
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Induction of mitotic cell death in cancer cells by small interference RNA suppressing the expression of RecQL1 helicase.
    Futami K; Kumagai E; Makino H; Goto H; Takagi M; Shimamoto A; Furuichi Y
    Cancer Sci; 2008 Jan; 99(1):71-80. PubMed ID: 17953710
    [TBL] [Abstract][Full Text] [Related]  

  • 4. RECQL1 and WRN proteins are potential therapeutic targets in head and neck squamous cell carcinoma.
    Arai A; Chano T; Futami K; Furuichi Y; Ikebuchi K; Inui T; Tameno H; Ochi Y; Shimada T; Hisa Y; Okabe H
    Cancer Res; 2011 Jul; 71(13):4598-607. PubMed ID: 21571861
    [TBL] [Abstract][Full Text] [Related]  

  • 5. RECQL1 DNA repair helicase: a potential therapeutic target and a proliferative marker against ovarian cancer.
    Sanada S; Futami K; Terada A; Yonemoto K; Ogasawara S; Akiba J; Yasumoto M; Sumi A; Ushijima K; Kamura T; Furuichi Y; Yano H
    PLoS One; 2013; 8(8):e72820. PubMed ID: 23951333
    [TBL] [Abstract][Full Text] [Related]  

  • 6. RECQL1 and WRN DNA repair helicases: potential therapeutic targets and proliferative markers against cancers.
    Futami K; Furuichi Y
    Front Genet; 2014; 5():441. PubMed ID: 25620975
    [TBL] [Abstract][Full Text] [Related]  

  • 7. RECQL1 plays an important role in the development of tongue squamous cell carcinoma.
    Tao J; Tao S; Han J; Zhou Z; Zhang X; Wang H; Chen R; Ji F; Zhu Y
    Cell Physiol Biochem; 2014; 33(5):1579-90. PubMed ID: 24854846
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Survivin knockdown by short hairpin RNA abrogates the growth of human hepatocellular carcinoma xenografts in nude mice.
    Zhang R; Ma L; Zheng M; Ren J; Wang T; Meng Y; Zhao J; Jia L; Yao L; Han H; Li K; Yang A
    Cancer Gene Ther; 2010 Apr; 17(4):275-88. PubMed ID: 19876077
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinicopathological and Functional Significance of RECQL1 Helicase in Sporadic Breast Cancers.
    Arora A; Parvathaneni S; Aleskandarany MA; Agarwal D; Ali R; Abdel-Fatah T; Green AR; Ball GR; Rakha EA; Ellis IO; Sharma S; Madhusudan S
    Mol Cancer Ther; 2017 Jan; 16(1):239-250. PubMed ID: 27837030
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Therapeutic effect for liver-metastasized tumor by sequential intravenous injection of anionic polymer and cationic lipoplex of siRNA.
    Hattori Y; Arai S; Kikuchi T; Ozaki KI; Kawano K; Yonemochi E
    J Drug Target; 2016 Apr; 24(4):309-317. PubMed ID: 26234899
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The level of RECQL1 expression is a prognostic factor for epithelial ovarian cancer.
    Matsushita Y; Yokoyama Y; Yoshida H; Osawa Y; Mizunuma M; Shigeto T; Futagami M; Imaizumi T; Mizunuma H
    J Ovarian Res; 2014 Nov; 7():107. PubMed ID: 25424877
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Suppression of tumor growth in lung cancer xenograft model mice by poly(sorbitol-co-PEI)-mediated delivery of osteopontin siRNA.
    Cho WY; Hong SH; Singh B; Islam MA; Lee S; Lee AY; Gankhuyag N; Kim JE; Yu KN; Kim KH; Park YC; Cho CS; Cho MH
    Eur J Pharm Biopharm; 2015 Aug; 94():450-62. PubMed ID: 26141346
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The efficacy of combination therapy using adeno-associated virus-TRAIL targeting to telomerase activity and cisplatin in a mice model of hepatocellular carcinoma.
    Wang Y; Huang F; Cai H; Wu Y; He G; Tan WS
    J Cancer Res Clin Oncol; 2010 Dec; 136(12):1827-37. PubMed ID: 20213096
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A study of the suppressive effect on human pancreatic adenocarcinoma cell proliferation and angiogenesis by stable plasmid-based siRNA silencing of c-Src gene expression.
    Zhao X; Li DC; Zhao H; Li Z; Wang JX; Zhu DM; Zhou J; Cen JN
    Oncol Rep; 2012 Mar; 27(3):628-36. PubMed ID: 22200682
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lentivirus-mediated RNAi knockdown of NUPR1 inhibits human nonsmall cell lung cancer growth in vitro and in vivo.
    Guo X; Wang W; Hu J; Feng K; Pan Y; Zhang L; Feng Y
    Anat Rec (Hoboken); 2012 Dec; 295(12):2114-21. PubMed ID: 22961798
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effects of cyclooxygenase-2 gene silencing by siRNA on cell proliferation, cell apoptosis, cell cycle and tumorigenicity of Capan-2 human pancreatic cancer cells.
    Zhong Y; Xia Z; Liu J; Lin Y; Zan H
    Oncol Rep; 2012 Apr; 27(4):1003-10. PubMed ID: 22200969
    [TBL] [Abstract][Full Text] [Related]  

  • 17. RECON syndrome is a genome instability disorder caused by mutations in the DNA helicase RECQL1.
    Abu-Libdeh B; Jhujh SS; Dhar S; Sommers JA; Datta A; Longo GM; Grange LJ; Reynolds JJ; Cooke SL; McNee GS; Hollingworth R; Woodward BL; Ganesh AN; Smerdon SJ; Nicolae CM; Durlacher-Betzer K; Molho-Pessach V; Abu-Libdeh A; Meiner V; Moldovan GL; Roukos V; Harel T; Brosh RM; Stewart GS
    J Clin Invest; 2022 Mar; 132(5):. PubMed ID: 35025765
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A small interfering RNA targeting proteinase-activated receptor-2 is effective in suppression of tumor growth in a Panc1 xenograft model.
    Iwaki K; Shibata K; Ohta M; Endo Y; Uchida H; Tominaga M; Okunaga R; Kai S; Kitano S
    Int J Cancer; 2008 Feb; 122(3):658-63. PubMed ID: 17935125
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nanoformulation of Apolipoprotein E3-Tagged Liposomal Nanoparticles for the co-Delivery of KRAS-siRNA and Gemcitabine for Pancreatic Cancer Treatment.
    Wang F; Zhang Z
    Pharm Res; 2020 Nov; 37(12):247. PubMed ID: 33216236
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Systemic delivery of siRNA specific to tumor mediated by atelocollagen: combined therapy using siRNA targeting Bcl-xL and cisplatin against prostate cancer.
    Mu P; Nagahara S; Makita N; Tarumi Y; Kadomatsu K; Takei Y
    Int J Cancer; 2009 Dec; 125(12):2978-90. PubMed ID: 19422046
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.